Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing in Peripheral Blood Mononuclear Cells of Waldenstrom Macroguloblinemia and IgM Monoclonal Gammopathy of Undetermined Significance

Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing in Peripheral Blood Mononuclear Cells of Waldenstrom Macroguloblinemia and IgM Monoclonal Gammopathy of Undetermined Significance - Detection of MYD88 L265P Mutation By Next Generation Deep Sequencing

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029676

Enrollment

Registered

2017-10-25

Start date

2017-02-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Waldenstrom macroglobulinaemia, IgM Monoclonal gammopathy of undetermined significance

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Waldenstrom Macroguloblinemia, Lymphoplasmacytic Lymphoma, and IgM Monoclonal Gammopathy of Undetermined Significance

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Sensitivity and sensitivity of NGS analysis for MYD88 L265P mutation	—

Countries

Japan

Contacts

Public ContactMasahiro Takeuchi

Chiba University Hospital Department of hematology

m-takeuchi@faculty.chiba-u.jp043-222-7171

Outcome results